IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences, Inc. (IDYA) is a healthcare company (biotechnology) based in the United States. The share price is $26.86, down 11.53% on the day, which values the company at $2.6B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$26.86−11.53% today
Market value
$2.6B
Funk Score
59/100
Against its own history
Well below its usual priceusual price $43.59
200-week average
$29.599% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

IDEAYA Biosciences, Inc. in more detail

IDYA trades at -6.4× next year's expected earnings, 71.1× sales. Measured against its own history, the price is 38% below what its usual multiples would imply ($43.59) — well below its usual price. It sits 9% below its 200-week average of $29.59.

Over the last five fiscal years IDEAYA Biosciences, Inc. has compounded revenue 62.1% a year. Its Funk Score is 59 out of 100 (financial strength 7.9, profitability 2.0, growth 8.7, value 4.9, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold IDYA, including Julian and Felix Baker (0.9% of the portfolio).

Superinvestors holding IDYA

1 of the investors tracked here report a position in their latest 13F filing.

IDEAYA Biosciences, Inc. (IDYA): questions and answers

What is IDEAYA Biosciences, Inc.'s market cap?

IDEAYA Biosciences, Inc. is valued at $2.6B at a share price of $26.86.

Is IDYA overvalued or undervalued?

Against its own history, IDYA is well below its usual price: the price is 38% below the $43.59 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is IDYA above its 200-week moving average?

No. IDYA is 9.2% below its 200-week average of $29.59. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is IDEAYA Biosciences, Inc. growing?

Over the last five fiscal years IDEAYA Biosciences, Inc.'s revenue grew 62.1% a year.

Does IDYA pay a dividend?

IDEAYA Biosciences, Inc. does not currently pay a regular dividend.

Which famous investors own IDYA?

In their latest quarterly filings, Julian and Felix Baker (0.9% of the portfolio) hold IDYA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “IDEAYA Biosciences, Inc. (IDYA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/IDYA

Underlying data: Yahoo Finance; company filings with the SEC.